Equities analysts predict that Alcentra Capital Corp (NASDAQ:ABDC) will announce sales of $8.15 million for the current quarter, Zacks reports. Two analysts have issued estimates for Alcentra Capital’s earnings, with estimates ranging from $7.92 million to $8.37 million. Alcentra Capital reported sales of $9.20 million during the same quarter last year, which indicates a negative year over year growth rate of 11.4%. The company is scheduled to report its next earnings results on Thursday, May 3rd.
On average, analysts expect that Alcentra Capital will report full year sales of $8.15 million for the current financial year, with estimates ranging from $31.06 million to $34.45 million. For the next fiscal year, analysts anticipate that the firm will post sales of $33.85 million per share. Zacks Investment Research’s sales averages are an average based on a survey of research analysts that follow Alcentra Capital.
A number of brokerages have recently issued reports on ABDC. ValuEngine cut Alcentra Capital from a “buy” rating to a “hold” rating in a report on Thursday. Raymond James Financial upgraded shares of Alcentra Capital from an “underperform” rating to a “market perform” rating in a research report on Thursday, January 11th. Finally, UBS Group upgraded shares of Alcentra Capital from an “underperform” rating to a “market perform” rating in a research report on Thursday, January 11th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company’s stock. Alcentra Capital has an average rating of “Hold” and an average price target of $12.83.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Stilwell Value LLC acquired a new position in Alcentra Capital during the fourth quarter valued at approximately $8,701,000. Pacific Ridge Capital Partners LLC acquired a new position in Alcentra Capital during the fourth quarter valued at approximately $1,171,000. BlackRock Inc. raised its position in Alcentra Capital by 18.0% during the fourth quarter. BlackRock Inc. now owns 89,703 shares of the asset manager’s stock valued at $753,000 after purchasing an additional 13,669 shares in the last quarter. Wasatch Advisors Inc. raised its position in Alcentra Capital by 151.5% during the fourth quarter. Wasatch Advisors Inc. now owns 85,813 shares of the asset manager’s stock valued at $720,000 after purchasing an additional 51,689 shares in the last quarter. Finally, Bramshill Investments LLC acquired a new position in Alcentra Capital during the fourth quarter valued at approximately $512,000. Institutional investors own 34.09% of the company’s stock.
Shares of Alcentra Capital (NASDAQ:ABDC) opened at $6.25 on Friday. Alcentra Capital has a 1-year low of $6.15 and a 1-year high of $14.73. The stock has a market capitalization of $110.10, a P/E ratio of 13.02 and a beta of 0.55.
Alcentra Capital announced that its board has authorized a share repurchase plan on Thursday, November 16th that allows the company to repurchase $2.50 million in shares. This repurchase authorization allows the asset manager to purchase shares of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s management believes its shares are undervalued.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 4th. Stockholders of record on Friday, March 30th will be given a $0.18 dividend. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 11.52%. Alcentra Capital’s payout ratio is 208.33%.
WARNING: “Alcentra Capital Corp (ABDC) Expected to Announce Quarterly Sales of $8.15 Million” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another domain, it was illegally copied and republished in violation of international trademark & copyright law. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2018/04/07/alcentra-capital-corp-abdc-expected-to-announce-quarterly-sales-of-8-15-million.html.
Alcentra Capital Company Profile
Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.
Get a free copy of the Zacks research report on Alcentra Capital (ABDC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.